Lumida
/HNGE
⌘K
Hinge Health Inc

Hinge Health Inc

HNGE
$88.59USD+0.37%+0.33 today

MARKET CAP

7.1B

P/E (TTM)

FWD P/E

DAY RANGE

$86 – $91

52W RANGE

$30
$96

AI Summary

Stalk
Sell NowMedium

HNGE has broken the multi-touch support cluster and confirmed a Stage 3 distribution phase, with price now below declining EMAs and support acting as resistance. The short-term downtrend and lack of mean-reversion signals favor selling into the current weakness. We will sell now on this breakdown, while a sustained reclaim above the 9EMA/20EMA zone or the former support near $88.60–$89.20 would invalidate this bearish bias.

  • Revenue rose 53% YoY to $213M in Q2 ’26; operating margin expanded to 29%.
  • Generated $100M in free cash flow (47% margin), funding $300M repurchase.
  • Forward P/E of 67.7x suggests limited upside.
Full analysis →
STATEMENT·Income statement
USD · GAAP
METRICFY 2025TREND
Sales, Adj.$587.9M
YoY %
P / Sales4.3x
EV / Sales4.6x
Gross Profit, Adj.$468.2M
YoY %
Margin %79.6%
EV / Gross Profit5.8x
EBITDA, Adj.$-541.2M
YoY %
Margin %-92.1%
EV / EBITDA-5.0x
EBIT$-546.4M
YoY %
Margin %-92.9%
EV / EBIT-4.9x
Net Income$-424.1M
YoY %
Net Margin-72.1%
EPS (GAAP)-$7.77
YoY %